Agency for Healthcare Research and Quality

Whole-Body Vibration Therapy for Osteoporosis: Technical Brief Number 10

Agency for Healthcare Research and Quality

$15.99

Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Comparative Effectiveness Review Number 73

Agency for Healthcare Research and Quality

$20.99

Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults: Comparative Effectiveness Review Number 33

Agency for Healthcare Research and Quality

$56.47

Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis: Comparative Effectiveness Review Number 77

Agency for Healthcare Research and Quality

$42.73

Migraine in Adults: Preventive Pharmacologic Treatments: Comparative Effectiveness Review Number 103

Agency for Healthcare Research and Quality

$42.97

2. The Patient-Centered Medical Home: Closing the Quality Gap: Revisiting the State of the Science

Agency for Healthcare Research and Quality

$23.99

Future Research Needs for Comparative Effectiveness of Treatments of Localized Prostate Cancer: Future Research Needs Paper Number 4

Agency for Healthcare Research and Quality

$19.99

Allocation of Scarce Resources During Mass Casualty Events: Evidence Report/Technology Assessment Number 207

Agency for Healthcare Research and Quality

$27.99

Assessing the Impact of Economic Evidence on Policymakers In Health Care - A Systematic Review

Agency for Healthcare Research and Quality

$20.99

The Guide to Clinical Preventive Services 2012: Recommendations of the U.S. Preventive Services Task Force

Agency for Healthcare Research and Quality

$21.99

Acute Migraine Treatment in Emergency Settings: Comparative Effectiveness Review Number 84

Agency for Healthcare Research and Quality

$23.99

Volume 5: Comparison of Translational Patterns in Two Nutrient-Disease Associations: Nutritional Research Series - Technical Review 17

Agency for Healthcare Research and Quality

$16.43

Angiotensin-Converting Enzyme Inhibitors (Aceis), Angiotensin II Receptor Antagonists (Arbs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update: Comparative Effectiveness Revi

Agency for Healthcare Research and Quality

$31.46

Primary Care Relevant Interventions for Tobacco Use Prevention and Cessation in Children and Adolescents: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis N

Agency for Healthcare Research and Quality

$20.99

Behavioral Counseling to Prevent Skin Cancer: Systematic Evidence Review to Update the 2003 U.S. Preventive Services Task Force Recommendation: Evidence Synthesis Number 82

Agency for Healthcare Research and Quality

$23.99

A Pilot Study Using Machine Learning and Domain Knowledge To Facilitate Comparative Effectiveness Review Updating

Agency for Healthcare Research and Quality

$15.99

Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness: Comparative Effectiveness Review Number 130

Agency for Healthcare Research and Quality

$24.99

Screening in Primary Care Settings for Illicit Drug Use: Staged Systematic Review for the United States Preventive Services Task Force: Evidence Synthesis Number 58

Agency for Healthcare Research and Quality

$21.99

Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults: Comparative Effectiveness Review Number 72

Agency for Healthcare Research and Quality

$23.99

Transition of Care for Acute Stroke and Myocardial Infarction Patients: From Hospitalization to Rehabilitation, Recovery, and Secondary Prevention: Evidence Report/Technology Assessment Number 202

Agency for Healthcare Research and Quality

$24.99

Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: Update of the Evidence for the U.S. Preventive Services Task Force: Evidence Synthe

Agency for Healthcare Research and Quality

$42.57

Primary Care Screening for Abdominal Aortic Aneurysm: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis Number 109

Agency for Healthcare Research and Quality

$23.99

5. Public Reporting as a Quality Improvement Strategy: Closing the Quality Gap: Revisiting the State of the Science (Evidence Report/Technology Assessment Number 208)

Agency for Healthcare Research and Quality

$42.73

Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (Aceis), Angiotensin II Receptor Antagonists (Arbs), or Direct Renin Inhibitors (Dris) for Treating Hypertension: Future Research Nee

Agency for Healthcare Research and Quality

$16.99

Screening for Hepatitis C Virus Infection in Adults: Comparative Effectiveness Review Number 69

Agency for Healthcare Research and Quality

$31.46

Maternal-Fetal Surgical Procedures: Technical Brief Number 5

Agency for Healthcare Research and Quality

$23.99

Treatment of Common Hip Fractures: Evidence Report/Technology Assessment Number 184

Agency for Healthcare Research and Quality

$25.99

3. Quality Improvement Interventions To Address Health Disparities: Closing the Quality Gap: Revisiting the State of the Science

Agency for Healthcare Research and Quality

$38.48

Migraine in Children: Preventive Pharmacologic Treatments: Comparative Effectiveness Review Number 108

Agency for Healthcare Research and Quality

$24.99

Venous Thromboembolism Prophylaxis in Orthopedic Surgery (Main Report): Comparative Effectiveness Review Number 49

Agency for Healthcare Research and Quality

$29.76